Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Bell Potter Healthcare Conference 2025
25 slides from Mach7 Technologies's conference presentation, Nov 18, 2025
Slide 1: Bell Potter Conference Presentation
ASX Announcement 18 November 2025 BELL POTTER CONFERENCE PRESENTATION Mach7 Technologies Limited (“M7T” or “the Company”) (ASX:M7T) provides the attached presentation which will be delivered by the CEO and Managing Director Teri Thomas at the Bell Potter Healthcare Conference today. Released on auth
Slide 2: Mach7 Technologies | ASX: M7T
For personal use only Mach7 Technologies | ASX: M7T
Slide 3: Disclaimer and forward looking statements
Disclaimer “Forward looking” statements Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities current as at the date
Slide 4: Introducing Mach7's CEO
Introducing Mach7’s CEO Commenced as CEO & Managing Director on 1 July 2025 For personal use only Teri has a distinguished career in healthcare technology, 1 executive leadership and in driving strategic growth. As CEO of Volpara Health Technologies Ltd (ASX:VHT), Teri led a remarkable 2 corporate t
Slide 5: Purpose
For personal use only Purpose We connect the right medical images, people, and insights, powering better care today and the AI-driven discoveries of tomorrow. The medical imaging industry faces challenges with fragmented data and vendor lock-in which slow down diagnostics and impact quality. Achievi
Slide 6: Our Solution: Enterprise Imaging Platform
Our Solution: Enterprise Imaging Platform For personal use only Enterprise Data Management Enterprise Diagnostic Viewing Vendor Neutral Archive eUnity Enterprise Diagnostic Viewer ✓ Consolidate ALL images across the enterprise ✓ Zero footprint HTML-5 viewer; 100% fidelity ✓ Allows customers to take
Slide 7: History of Mach7 – Key Milestones
History of Mach7 – Key Milestones For personal use only Mach7 Mach7 acquires Mach7 lists on Mach7 wins VHA Initial go-live of Technologies Client Outlook ASX NTP contract1 NTP contract founded (eUnity Viewer) 2007 2016 2020 2023 2010 2018 2022 2025 Mach7 signs Recognised as Best in Appointment First
Slide 8: Mach7 by the Numbers
Mach7 by the Numbers For personal use only 94 200+ 98% customer sites in employees in 14 countries Customer 7 countries Incl. US Govt retention1 Offices in U.S., Canada, Malaysia A$33.8M #1 FY25 Revenue In KLAS viewer & Singapore segment for value 1. Customer retention rate is based on the number of
Slide 9: Our Key Differentiators
Our Key Differentiators Data Independence & Sovereignty 1 Vendor Neutral Architecture allows customers full control and unrestricted access to their data. For personal use only Modular End-to-End Architecture 2 Mach7 offers modular components enabling full enterprise to standalone tools. Advanced Or
Slide 10: Enterprise Imaging and AI Market Growth Trends
Enterprise Imaging and AI Market Growth Trends For personal use only Enterprise Imaging AI in Medical Market Growth Imaging Expansion Enterprise Imaging market AI in Medical Imaging market valued at US$2.1B in 2024 is projected to grow rapidly at 20- expected to reach US$4.1B by 35% CAGR from US$1.3
Slide 11: Emergent and Differentiating Trends from Customer and Analyst Input
Emergent and Differentiating Trends from Customer and Analyst Input For personal use only Teleradiology Interoperability AI and Data Cybersecurity and Remote & Integration Orchestration Priority Reading Breaking data silos The rise of AI in Security features and Growing need for fast with open APIs
Slide 12: Solving Challenges in Close Customer Collaboration
Solving Challenges in Close Customer Collaboration For personal use only Customer Pain Pain Removed Delight Created Fragmented data, slow Mach7 unifies data silos, Sub-second, seamless image access and vendor delivering true data image access accelerates lock-ins. independence and vendor diagnostics
Slide 13: Strategic Directions
Strategic Directions From archive to architecture. For personal use only The imaging industry is undergoing rapid change, costs are soaring, talent is scarce, and data silos persist. Agentic AI is emerging as the 1 catalyst for efficiency, innovation, and opportunities for Mach7 to capture market le
Slide 14: Product and Innovation Roadmap
Product and Innovation Roadmap For personal use only New Additional architecture eUnity expansion capabilities launch Enable Agentic AI through open Evolution of eUnity into a full tele-imaging Embedding telemetry and AI-driven APIs that unify data flow, platform, uniting radiology, advanced optimis
Slide 15: Asia: From Quiet Outpost to Strategic Growth Engine
Asia: From Quiet Outpost to Strategic Growth Engine For personal use only 1 Establishing a low-cost innovation hub. Capitalising on VNA growth in Asia and the Middle East leveraging our impending CE Mark and regional 2 49% 58% position for capital sales in enterprise and government 32% opportunities
Slide 16: Operating Model and Framework
Operating Model and Framework Purpose and Value Agenda For personal use only Purpose anchors decisions to improve patient care; value agenda aligns resources to customer outcomes and monetisation models. Organisational Structure Structure empowers accountable mission teams supported by AI-enabled ex
Slide 17: Commercial Transformation and Innovation
Commercial Transformation and Innovation Driving profitable growth through innovation, execution and accountability. For personal use only • Comprehensive leadership refresh – Realigned leadership to boost execution, innovation and sustainable growth with sharper focus and accountability. 49% 58% 32
Slide 18: Transforming Our Customer Engagement
Transforming Our Customer Engagement Flight Crew - revitalising how Mach7 serves its customers and partners. For personal use only One multi-disciplinary customer designated team Led by Advocate for Customer Experience (ACE) Clear accountability improves support response time Delivers consistent Mac
Slide 19: The Mach7 Loop
The Mach7 Loop Our cycle of compounding growth For personal use only 18
Slide 20: Outlook
Outlook Mach7 is well positioned to execute its strategic ambitions with a refreshed leadership team driving For personal use only technical, cultural, and operational changes. We strive to reshape how imaging data powers healthcare and to translate innovation into financial performance. Financial d
Slide 21: Appendix
For personal use only Appendix
Slide 22: Mach7 CLIMBS Culture Code
Mach7 CLIMBS Culture Code Culture is the execution engine of our strategy. For personal use only Customer First Principle Learn and Grow Innovate for Impact Minimise complexity and move Build with ownership Sell and grow together 21
Slide 23: Q1 FY26 Financial Highlights
Q1 FY26 Financial Highlights Reset quarter as we begin to execute a full commercial transformation. For personal use only VHA NTP initial go-live A$29.6M A$23.5M CARR1 ARR2 Run Rate Phase 1 limited go-live -A$0.4M on 30 Jun 2025 +A$0.1M on 30 June 2025 In constant currency In constant currency A$18.
Slide 24: FY25 Financial Highlights
FY25 Financial Highlights For personal use only A$33.8M A$25.3M A$30.2M A$23.5M Revenue Recurring Revenue3 CARR4 ARR5 Run Rate +A$4.7M or +16% on PCP1 +A$4.3M or +20% on PCP +A$2.3M or +8% on PCP +A$1.5M or +7% on PCP In line with FY25 75% of total revenue In line with updated Guidance2 FY25 Guidanc
Slide 25: Contact Us
For personal use only Contact Us Investor Relations, Mach7 Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 This document was authorised for release to the ASX by Teri Thomas, Managing Director and Chief Executive Officer Mach
Mach7 Technologies — Bell Potter Healthcare Conference 2025 on 6ix